TORONTO, Dec. 03, 2020 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (CSE: FTRP) (OTCBB: FTRPF) ("Field Trip"), a leader in the development and delivery of psychedelic therapies, is pleased to...
Pre-clinical studies demonstrate potential of FT-104, its novel psychedelic molecule, as preferable option for psychedelic therapies, with comparable potency to psilocybin and shorter duration4...
TORONTO, Nov. 25, 2020 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (CSE: FTRP, OTCBB: FTRPF) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced...
TORONTO, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (CSE: FTRP, OTCBB: FTRPF) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, and WHOOP...
AMSTERDAM, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (CSE: FTRP, OTCBB: FTRPF) ("Field Trip"), a global leader in the development and delivery of technology-enabled psychedelic...
TORONTO, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (CSE: FTRP) ("Field Trip"), one of the leaders in the development and delivery of psychedelic therapies, announced today that it...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 1.05 | 1.05 | 1.05 | 0 | 0 | CS |
4 | 0 | 0 | 1.05 | 1.05 | 1.05 | 0 | 0 | CS |
12 | 0 | 0 | 1.05 | 1.05 | 1.05 | 0 | 0 | CS |
26 | 0 | 0 | 1.05 | 1.05 | 1.05 | 0 | 0 | CS |
52 | 0 | 0 | 1.05 | 1.05 | 1.05 | 0 | 0 | CS |
156 | -1.7 | -61.8181818182 | 2.75 | 2.76 | 0.96 | 140 | 1.7591332 | CS |
260 | -2.26 | -68.2779456193 | 3.31 | 9.88 | 0.96 | 15261 | 5.14969396 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales